Menopause Hormone Therapy: Where We Are Now
Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT.
- Discuss the benefits and risks associated with menopause hormone therapy.
- Identify treatment options for treating hot flashes in the postmenopausal women.
- Prescribe menopause hormone therapy.
Martin A. Quan, MD
Professor of Clinical Family Medicine
Director, Office of Continuing Medical Education
Vice Chair for Academic Affairs
David Geffen School of Medicine at UCLA
Los Angeles, CA
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Martin A. Quan, MD: No relevant financial relationships disclosed.
Charles Vega, MD, FAAFP (moderator): No relevant financial relationships disclosed.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
AMA PRA Category 1 Credits™
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Pri-Med Institute and the David Geffen School of Medicine at UCLA. Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.
This activity is approved for 1.00 contact hour of continuing education, which includes 0.667 hour of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 1.00 AANP Contact Hours
- 0.67 Pharmacology
- 0.67 AANP Pharmacology Contact Hours
- 1.00 MOC
- 1.00 AMA PRA Category 1 Credit™
This course is offered through Pri-Med.
To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!